These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25441491)

  • 41. The association of an elevated Th/Ts ratio and lupus anticoagulant with symptomatic osteonecrosis in systemic lupus erythematosus patients.
    Hou R; Lei J; Xue D; Jing Y; Mi L; Guo Q; Xu K; Zhang L
    Front Immunol; 2024; 15():1288234. PubMed ID: 38384449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systemic lupus erythematosus and avascular bone necrosis.
    Nilsen KH
    N Z Med J; 1977 Jun; 85(589):472-5. PubMed ID: 271846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis.
    Rizk A; Gheita TA; Nassef S; Abdallah A
    Int J Rheum Dis; 2012 Jun; 15(3):261-7. PubMed ID: 22212605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of osteonecrosis in systemic lupus erythematosus.
    Mont MA; Jones LC
    Rheum Dis Clin North Am; 2000 May; 26(2):279-309, vi. PubMed ID: 10768213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for avascular bone necrosis in systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    Br J Rheumatol; 1998 Aug; 37(8):895-900. PubMed ID: 9734682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of prevalent vertebral fractures on the quality of life of patients with systemic lupus erythematosus.
    Garciá-Carrasco M; Mendoza-Pinto C; Riebeling C; Sandoval-Cruz M; Nava A; Etchegaray-Morales I; Jiménez-Hernández M; Montiel-Jarquín A; López-Colombo A; Cervera R
    Isr Med Assoc J; 2011 Jun; 13(6):333-7. PubMed ID: 21809728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjusted mean Systemic Lupus Erythematosus Disease Activity Index-2K is a predictor of outcome in SLE.
    Ibañez D; Gladman DD; Urowitz MB
    J Rheumatol; 2005 May; 32(5):824-7. PubMed ID: 15868616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of osteonecrosis in systemic lupus erythematosus: a review.
    Ehmke TA; Cherian JJ; Wu ES; Jauregui JJ; Banerjee S; Mont MA
    Curr Rheumatol Rep; 2014; 16(9):441. PubMed ID: 25074031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head.
    Massari L; Fini M; Cadossi R; Setti S; Traina GC
    J Bone Joint Surg Am; 2006 Nov; 88 Suppl 3():56-60. PubMed ID: 17079368
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Osteonecrosis in systemic lupus erythematosus. Report of 3 cases].
    Marrón A; Formiga F; Valverde J; Mitjavila F; Pac M; Moga I
    An Med Interna; 1997 Jun; 14(6):307-9. PubMed ID: 9410105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
    Akawatcharangura P; Taechakraichana N; Osiri M
    Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Juvenile systemic lupus erythematosus in Portugal: clinical and immunological patterns of disease expression in a cohort of 56 patients.
    Cabral M; Escobar C; Conde M; Ramos M; Melo Gomes JA
    Acta Reumatol Port; 2013; 38(4):274-85. PubMed ID: 24435032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bilateral osteonecrosis of the navicular and medial cuneiform in a patient with systemic lupus erythematosus: a case report.
    Greenhagen RM; Crim BE; Shinabarger AB; Burns PR
    Foot Ankle Spec; 2012 Jun; 5(3):180-4. PubMed ID: 22441501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control study.
    Barrera-Vargas A; Quintanar-Martínez M; Merayo-Chalico J; Alcocer-Varela J; Gómez-Martín D
    Rheumatology (Oxford); 2016 Mar; 55(3):429-35. PubMed ID: 26396262
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factors for osteonecrosis in systemic lupus erythematosus.
    Mont MA; Glueck CJ; Pacheco IH; Wang P; Hungerford DS; Petri M
    J Rheumatol; 1997 Apr; 24(4):654-62. PubMed ID: 9101497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women.
    Sinigaglia L; Varenna M; Binelli L; Zucchi F; Ghiringhella D; Gallazzi M; Limonta M; Zeni S; Fantini F
    J Rheumatol; 1999 Jun; 26(6):1280-4. PubMed ID: 10381043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MBL2 gene variants coding for mannose-binding lectin deficiency are associated with increased risk of nephritis in Danish patients with systemic lupus erythematosus.
    Tanha N; Troelsen L; From Hermansen ML; Kjær L; Faurschou M; Garred P; Jacobsen S
    Lupus; 2014 Oct; 23(11):1105-11. PubMed ID: 24850777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors associated with active systemic lupus erythematosus after endstage renal disease.
    Szeto CC; Li PK; Wong TY; Leung CB; Lui SF
    J Rheumatol; 1998 Aug; 25(8):1520-5. PubMed ID: 9712094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atraumatic osteonecrosis of the humeral head.
    Mont MA; Payman RK; Laporte DM; Petri M; Jones LC; Hungerford DS
    J Rheumatol; 2000 Jul; 27(7):1766-73. PubMed ID: 10914865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus.
    Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
    Lupus; 2014 Mar; 23(3):327-34. PubMed ID: 24297642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.